330 related articles for article (PubMed ID: 19193653)
1. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors.
Oh D; Ahn YC; Park HC; Lim DH; Han Y
Jpn J Clin Oncol; 2009 Mar; 39(3):151-7. PubMed ID: 19193653
[TBL] [Abstract][Full Text] [Related]
2. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
4. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
[TBL] [Abstract][Full Text] [Related]
5. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
6. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
[TBL] [Abstract][Full Text] [Related]
7. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
[TBL] [Abstract][Full Text] [Related]
11. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
12. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
Harder EM; Park HS; Chen ZJ; Decker RH
Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
[TBL] [Abstract][Full Text] [Related]
14. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
Tsujino K; Hirota S; Kotani Y; Kado T; Yoden E; Fujii O; Soejima T; Adachi S; Takada Y
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1100-5. PubMed ID: 16373082
[TBL] [Abstract][Full Text] [Related]
15. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans.
Tomita N; Kodaira T; Matsuo M; Furutani K; Tachibana H; Daimon T; Shimizu H
Technol Cancer Res Treat; 2010 Aug; 9(4):407-15. PubMed ID: 20626206
[TBL] [Abstract][Full Text] [Related]
16. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
17. Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery.
Dang J; Li G; Zang S; Zhang S; Yao L
Lung Cancer; 2014 Dec; 86(3):329-33. PubMed ID: 25454199
[TBL] [Abstract][Full Text] [Related]
18. The relationship between dosimetric factors, side effects, and survival in patients with non-small cell lung cancer treated with definitive radiotherapy.
Okumus D; Sarihan S; Gozcu S; Sigirli D
Med Dosim; 2017 Autumn; 42(3):169-176. PubMed ID: 28506589
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy.
Zhou Z; Song X; Wu A; Liu H; Wu H; Wu Q; Liu Y; Li Y; Cai Y; Liang S
Sci Rep; 2017 Jun; 7(1):2748. PubMed ID: 28584268
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]